These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20344870)

  • 21. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
    Lunenburg CATC; Gasse C
    Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacogenetic challenges in the treatment of mental diseases].
    Sukhanov VA; Piruzian LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):83-6. PubMed ID: 15554149
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.
    Smoller JW
    CNS Spectr; 2006 Mar; 11(3 Suppl 3):5-7. PubMed ID: 17760223
    [No Abstract]   [Full Text] [Related]  

  • 26. [Personalized medicine in psychiatry -- an old concept from a new aspect].
    Molnar JM
    Neuropsychopharmacol Hung; 2012 Mar; 14(1):2-3. PubMed ID: 22427465
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.
    Ramey-Hartung B; El-Mallakh RS; Reynolds KK
    Clin Lab Med; 2008 Dec; 28(4):627-43. PubMed ID: 19059067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of CYP2D6 genotyping in psychiatry.
    Loovers HM; van der Weide J
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1065-77. PubMed ID: 19572825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomics and the future of pharmacotherapy in psychiatry.
    Malhotra AK; Lencz T; Correll CU; Kane JM
    Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphism of cytochrome P450 and methods for its determination.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Prague Med Rep; 2006; 107(4):383-93. PubMed ID: 17402551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized drug therapy; the genome, the chip and the physician.
    Lewis LD
    Br J Clin Pharmacol; 2005 Jul; 60(1):1-4. PubMed ID: 15963086
    [No Abstract]   [Full Text] [Related]  

  • 34. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of mood disorders: what clinicians need to know.
    Laje G
    CNS Spectr; 2013 Oct; 18(5):272-84. PubMed ID: 24050155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system.
    Ingelman-Sundberg M; Sim SC
    Biochem Biophys Res Commun; 2010 May; 396(1):90-4. PubMed ID: 20494117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacogenetics in psychiatry: how far are we from clinical application?].
    Daray FM; Maffia PC; Rothlin RP; Errasti AE
    Vertex; 2012; 23(104):299-309. PubMed ID: 23170302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of pharmacogenetics: implications for clinical psychiatry.
    Ng CH; Schweitzer I; Norman T; Easteal S
    Aust N Z J Psychiatry; 2004 Jul; 38(7):483-9. PubMed ID: 15255819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the role of pharmacogenetics in clinical psychiatry?
    Lombard J; Doraiswamy PM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):1-4. PubMed ID: 23189950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.
    Kaneko A; Lum JK; Yaviong L; Takahashi N; Ishizaki T; Bertilsson L; Kobayakawa T; Björkman A
    Pharmacogenetics; 1999 Oct; 9(5):581-90. PubMed ID: 10591538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.